-
BEAM Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Beam Therapeutics (BEAM)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 236.75 mm | 236.75 mm | 236.75 mm | 236.75 mm | 236.75 mm | 236.75 mm |
Cash burn (monthly) | 19.18 mm | 351.17 k | 35.50 mm | 15.50 mm | (no burn) | 4.08 mm |
Cash used (since last report) | 53.45 mm | 978.41 k | 98.91 mm | 43.20 mm | n/a | 11.37 mm |
Cash remaining | 183.31 mm | 235.77 mm | 137.84 mm | 193.56 mm | n/a | 225.38 mm |
Runway (months of cash) | 9.6 | 671.4 | 3.9 | 12.5 | n/a | 55.2 |
13F holders | Current |
---|---|
Total holders | 118 |
Opened positions | 44 |
Closed positions | 114 |
Increased positions | 28 |
Reduced positions | 29 |
13F shares | Current |
---|---|
Total value | 924.51 bn |
Total shares | 51.32 mm |
Total puts | 278.50 k |
Total calls | 617.80 k |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
Farallon Capital Management | 7.91 mm | $185.40 bn |
ARK Investment Management | 7.63 mm | $178.68 bn |
ARCH Venture Fund IX | 5.84 mm | $0.00 |
Arch Venture | 5.44 mm | $127.53 bn |
Farallon Capital Partners | 3.95 mm | $98.86 mm |
STT State Street | 3.49 mm | $81.82 bn |
CMTDF Sumitomo Mitsui Trust | 2.22 mm | $52.12 bn |
Redmile | 1.70 mm | $39.90 bn |
BLVGF Bellevue | 1.42 mm | $33.23 bn |
T. Rowe Price | 1.39 mm | $32.66 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Dec 24 | Giuseppe Ciaramella | Common Stock | Option exercise | Acquire M | No | No | 0.67 | 53,500 | 35.85 k | 162,650 |
17 Dec 24 | Giuseppe Ciaramella | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.67 | 53,500 | 35.85 k | 6,505 |
2 Dec 24 | Chirfi Guindo | Stock Option Common Stock | Grant | Acquire A | No | No | 28.3 | 39,086 | 1.11 mm | 39,086 |
6 Nov 24 | Giuseppe Ciaramella | Common Stock | Sell | Dispose S | No | Yes | 26.3559 | 51,110 | 1.35 mm | 109,150 |